Intervene before pain becomes chronic
The PAIN2020 research project is testing early diagnosis and treatment approaches to prevent pain patients' symptoms from becoming chronic / Patients from all statutory health insurance funds can participate
Millions of people in Germany suffer from chronic pain. It is estimated that between 10 and 20 percent of the total population suffers from chronic pain. The basic idea behind the nationwide PAIN2020 research project is to intervene at an early stage before the pain becomes chronic. The Interdisciplinary Pain Center (ISZ) at the Medical Center - University of Freiburg is the responsible PAIN2020 center for Baden-Württemberg and thus the only cooperation partner in southwest Germany. Participating patients benefit from early diagnosis and access to new treatment approaches tested in the study to prevent pain from becoming chronic. All patients with statutory health insurance can now take part.
"The project is an important step towards being able to help particularly vulnerable people in future, even before the pain becomes chronic. In the research project, we are investigating how we can counteract such pain chronification," says Dr. Kristin Kieselbach, Medical Director of the Interdisciplinary Pain Center at the Medical Center - University of Freiburg. At the heart of the newly tested treatment approaches is a comprehensive examination of those affected in the form of an interdisciplinary multimodal assessment: a team of specialists, physiotherapists and psychologists examine the pain patients and work together to develop a therapy recommendation tailored to the patient's individual needs. Patients can actively shape their pain therapy through joint discussions and consultations.
The PAIN2020 research project
PAIN2020 was launched almost two years ago on the initiative of the German Pain Society (Deutsche Schmerzgesellschaft e.V.) and BARMER. 26 pain medicine centers across Germany are involved in the research project. PAIN2020 is funded by the Innovation Fund of the Joint Federal Committee (G-BA) and will run for four years. A total of 4,500 patients are to be included in the program nationwide. In the PAIN2020 treatment program, new services not previously available in statutory health insurance will be tested and compared with treatment procedures in standard care. The aim is to transfer the examination and treatment approaches used in the research project to standard care at the end of the study. "In this way, we want to improve the quality and efficiency of care for all pain patients in the long term," says Kieselbach.
Participants wanted for PAIN2020!
Participation in the study is possible if the person is at least 18 years old and has risk factors for pain chronification. These include, for example, pain symptoms that have not improved or have improved only slightly in the last six weeks or pain that has occurred repeatedly in the last two years. Interested parties in Baden-Württemberg can contact the Interdisciplinary Pain Center of the Uniklinik Freiburg at schmerz@uniklinik-freiburg.de.
Further information can be found at
https://www.uniklinik-freiburg.de/schmerzzentrum/neues-in-der-schmerztherapie/pain2020.html
Test the participation option:
www.pain2020.de/patienteninformationen
Contact
Dr. Kristin Kieselbach
Medical Director
Interdisciplinary Pain Center ISZ
Medical Center - University of Freiburg
Phone 0761 270-50280
Back
Medical Center - University of Freiburg
Central Information
Phone: 0761 270-0
info@uniklinik-freiburg.de
For press inquiries:
Corporate Communications
Breisacher Straße 153
79110 Freiburg
Phone: 0761 270-84830
kommunikation@uniklinik-freiburg.de